Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Study
NCT ID: NCT03282695
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
70 participants
OBSERVATIONAL
2018-03-09
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Ozone Therapy for Lumbar Herniated Disc
NCT00566007
A Trial of Percutaneous Lumbar Discectomy Combined With Ozone for Treatment of LDH
NCT02372032
Combined Therapy for Cervical Disc Herniation
NCT06995066
The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease
NCT07085247
Safety and Effectiveness Study of the AO-1000 Device to Treat Contained Herniated Discs
NCT01339377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objective of this prospective, post-authorization follow-up study is to estimate the cost-effectiveness of ozone therapy (compared to standard care) in patients with disc herniation waiting for surgery (by microdiscectomy). Besides utilities of patients with disc herniation on a waiting list for surgery will be estimated, social/economic burden of disc herniation will be quantified and a decision aid will be developed and applied.
The main outcome measures are "Direct hospital cost", "Percentage of executed surgeries" and "Change in sciatic pain". In addition, data on health-related quality of life and resource utilization will be collected which will permit to estimate the incremental cost-effectiveness ratio (ICER), comparing incremental costs and quality adjusted life years (QALY).
The variables will be collected at the beginning, on the day of treatment and at 1, 3, 6, 12 and 24 months. The enrollment period will be 24 months. The follow-up period will be 24 months.
The results of the study will allow a better understanding of the value of ozone therapy in the management of patients on the waiting list for herniated disc surgery. In addition, it will contribute to the development of a more patient-centered health system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgery
Patients on waiting list for surgery (by discectomy/microdiscectomy) who reject ozone infiltration during waiting time.
These patients will receive standard pain treatment until the planned surgery.
No interventions assigned to this group
Ozone
Patients on waiting list for surgery (by discectomy/microdiscectomy) who accept treatment by ozone infiltration during waiting time.
These patients will be treated primarily by ozone therapy: Infiltration of intradiscal O3/O2 + foraminal infiltration of O3/O2 + corticoid + anesthetic.
These patients will receive standard pain treatment until the planned surgery.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evaluated and diagnosed by the Neurosurgery Department, having been chosen as an appropriate candidate for surgery consisting in discectomy or microdiscectomy, after meeting the following two criteria: 1) Sciatic pain, with a visual analogue scale (VAS) intensity ≥ 5, despite 6 weeks of conservative management, wether it exists lumbar pain or not and 2) Radiating pain that matches the MRI image showing one or more herniated discs (not to be considered those patients with two herniated discs and symptoms attributable to only one of the herniated discs).
* Included in the surgery waiting list for a discectomy or microdiscectomy.
* Patients who have signed and dated the study 's specific informed consent.
* Calcified and/or migrated herniated disc, and/or with a severe neurological deficits (cauda equine syndrome).
* Herniated disc with surgical indication of laminectomy and/or arthrodesis (massive extrusion, sign of instability or other conditions under the neurosurgeon judgment).
* Relevant clinical paresis that does not improve despite 6 weeks of full conservative management (patients with severe pain and mild paresis that only shows up in the physical exam are not to be excluded, but those who present with paresis as the main symptom -"clinically relevant"- must be).
* Simultaneous symptomatic cervical or dorsal herniated discs.
* Previous lumbar spine surgery.
* Concomitant spine conditions that may be causing symptoms or have indication for surgery (such as fractures or tumors).
* Known allergy to ozone.
* Those who are uncapable to fill in the scales used to measure variables in the study, like the visual analogue scale (VAS), Roland-Morris and SF-12 questionnaires.
* Those who are unable or do not wish to fulfill the study 's protocol (answer questions to collect the data).
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Servicio Canario de Salud
OTHER
Red de Investigación en Servicios de Salud en Enfermedades Crónicas
OTHER
Instituto de Salud Carlos III
OTHER_GOV
Colegio Oficial de Médicos de Las Palmas
UNKNOWN
Bernardino Clavo, MD, PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bernardino Clavo, MD, PhD
MD. PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernardino Clavo, MD, PhD
Role: STUDY_CHAIR
Dr. Negrín University Hospital, Las Palmas, Spain
Pedro G. Serrano-Aguilar, MD, PhD
Role: STUDY_DIRECTOR
Servicio de Evaluación. Servicio Canario de Salud. Spain
Renata Linertová, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Fundación Canaria de Investigación Sanitaria (FUNCANIS)
Adam Szolna, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Dr. Negrín University Hospital, Las Palmas. Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Negrin University Hospital
Las Palmas de Gran Canaria, Las Palmas, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hansson E, Hansson T. The cost-utility of lumbar disc herniation surgery. Eur Spine J. 2007 Mar;16(3):329-37. doi: 10.1007/s00586-006-0131-y. Epub 2006 May 9.
Luhmann D, Burkhardt-Hammer T, Borowski C, Raspe H. Minimally invasive surgical procedures for the treatment of lumbar disc herniation. GMS Health Technol Assess. 2005 Nov 15;1:Doc07.
Magalhaes FN, Dotta L, Sasse A, Teixera MJ, Fonoff ET. Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2012 Mar-Apr;15(2):E115-29.
Sherman J, Cauthen J, Schoenberg D, Burns M, Reaven NL, Griffith SL. Economic impact of improving outcomes of lumbar discectomy. Spine J. 2010 Feb;10(2):108-16. doi: 10.1016/j.spinee.2009.08.453. Epub 2009 Oct 12.
Tosteson AN, Skinner JS, Tosteson TD, Lurie JD, Andersson GB, Berven S, Grove MR, Hanscom B, Blood EA, Weinstein JN. The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: evidence from the Spine Patient Outcomes Research Trial (SPORT). Spine (Phila Pa 1976). 2008 Sep 1;33(19):2108-15. doi: 10.1097/brs.0b013e318182e390.
Related Links
Access external resources that provide additional context or updates about the study.
Report (June 2016) about Ozone therapy in disc herniation, from the Health Technology Assessment (HTA) Unit, Canary Health Service, Spain
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BCV-OZO-2016-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.